Look to "Blueprint" to understand new EPA requirements on hazardous drug waste
Medical Environment Update, March 1, 2019
This is an excerpt from a member only article. To read the article in its entirety, please login or subscribe to Medical Environment Update.
Consider managing all your pharmaceuticals as hazardous waste, especially if you are a smaller facility. And warn your C-suite that you’ll be scrutinized for compliance once new environmental regulations take effect.
The Environmental Protection Agency (EPA) has put a lot of time and effort into revising the federal Resource Conservation and Recovery Act (RCRA). They will want to see facilities implementing the newly finalized “Management Standards for Hazardous Waste Pharmaceuticals and Amendment to the P075 Listing for Nicotine,” says Charlotte A. Smith, RPh, MS, a senior regulatory advisor and founder of PharmEcology Services, now a part of WM Sustainability Services.
The final rule will become effective six months after it is published in the Federal Register. While the pre-published version was signed and posted on the EPA’s website, as of late January it had not been officially posted in the Federal Register.
This is an excerpt from a member only article. To read the article in its entirety, please login or subscribe to Medical Environment Update.
Related Products
Most Popular
- Articles
-
- Don't forget the three checks in medication administration
- Note similarities and differences between HCPCS, CPT® codes
- Complications from immobility by body system
- OB services: Coding inside and outside of the package
- Q&A: Primary, principal, and secondary diagnoses
- Differentiate between types of wound debridement
- The consequences of an incomplete medical record
- Nursing responsibilities for managing pain
- Practice the six rights of medication administration
- ICD-10-CM coma, stroke codes require more specific documentation
- E-mailed
-
- CDC alert: Screen for international travel as Ebola cases increase
- Differentiate between types of wound debridement
- Correctly bill ancillary bedside procedures in addition to the room rate
- Q&A: Utilization Review Committee Membership
- Q&A: A second look at encephalopathy as integral to seizures/CVA
- Performing a SWOT analysis
- Leadership training for charge nurses
- Intravenous therapy guidelines
- Helping Charge Nurses understand their leadership role (Part 2 of 3)
- Coding, billing, and documentation tips for teaching physicians, interns, residents, and students
- Searched